| signal transduction involved in dna integrity checkpoint | GO:0072401 | 3 | 0.994 | Human |
| regulation of kinase activity | GO:0043549 | 249 | 0.991 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.989 | |
| activation of mapkkk activity | GO:0000185 | 1 | 0.987 | |
| g1 s transition of mitotic cell cycle | GO:0000082 | 57 | 0.983 | Human Mouse |
| positive regulation of apoptotic process involved in mammary gland involution | GO:0060058 | 4 | 0.980 | |
| cell cycle arrest | GO:0007050 | 37 | 0.973 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.965 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.964 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.961 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.960 | |
| fibroblast proliferation | GO:0048144 | 35 | 0.952 | Human |
| negative regulation of blood vessel endothelial cell migration | GO:0043537 | 3 | 0.943 | |
| negative regulation of fibroblast proliferation | GO:0048147 | 14 | 0.940 | |
| negative regulation of oxidative stress induced intrinsic apoptotic signaling pathway | GO:1902176 | 4 | 0.937 | |
| response to endoplasmic reticulum stress | GO:0034976 | 53 | 0.932 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.926 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.912 | |
| gland development | GO:0048732 | 330 | 0.912 | Mouse |
| negative regulation of leukocyte differentiation | GO:1902106 | 51 | 0.908 | |
| apoptotic process involved in mammary gland involution | GO:0060057 | 4 | 0.903 | |
| positive regulation of transcription from rna polymerase ii promoter in response to stress | GO:0036003 | 3 | 0.899 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.895 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.880 | |
| negative regulation of phosphatidylinositol 3 kinase activity | GO:0043553 | 1 | 0.878 | |
| cellular response to radiation | GO:0071478 | 28 | 0.851 | |
| signal transduction involved in cell cycle checkpoint | GO:0072395 | 3 | 0.848 | Human |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.847 | |
| oocyte axis specification | GO:0007309 | 2 | 0.846 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.839 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.833 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.833 | Mouse |
| regulation of transcription from rna polymerase ii promoter in response to stress | GO:0043618 | 8 | 0.829 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.825 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.821 | |
| response to acid chemical | GO:0001101 | 111 | 0.812 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.810 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.807 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 45 | 0.807 | |
| regulation of mitochondrial membrane permeability | GO:0046902 | 17 | 0.805 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.804 | |
| cation transport | GO:0006812 | 399 | 0.804 | Mouse |
| signal transduction involved in dna damage checkpoint | GO:0072422 | 3 | 0.803 | Human |
| sphingolipid metabolic process | GO:0006665 | 45 | 0.802 | |
| intracellular signal transduction involved in g1 dna damage checkpoint | GO:1902400 | 3 | 0.800 | Human |
| intrinsic apoptotic signaling pathway in response to oxidative stress | GO:0008631 | 19 | 0.797 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.790 | |
| positive regulation of cardiac muscle cell apoptotic process | GO:0010666 | 3 | 0.776 | |
| regulation of dna templated transcription in response to stress | GO:0043620 | 9 | 0.773 | |
| muscle tissue development | GO:0060537 | 308 | 0.763 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.755 | |
| angiogenesis | GO:0001525 | 201 | 0.750 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.737 | |
| germ cell development | GO:0007281 | 185 | 0.737 | |
| activation of mapkk activity | GO:0000186 | 15 | 0.727 | |
| response to oxidative stress | GO:0006979 | 123 | 0.722 | |
| mitotic g1 dna damage checkpoint | GO:0031571 | 4 | 0.716 | Human |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.712 | Human |
| microtubule based process | GO:0007017 | 236 | 0.712 | Mouse |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.710 | Human |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.703 | |
| digestive tract development | GO:0048565 | 190 | 0.695 | |
| release of cytochrome c from mitochondria | GO:0001836 | 23 | 0.691 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.683 | |
| regionalization | GO:0003002 | 337 | 0.683 | |
| cellular response to gamma radiation | GO:0071480 | 4 | 0.682 | |
| response to radiation | GO:0009314 | 165 | 0.679 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.671 | |
| metanephric glomerular mesangium development | GO:0072223 | 3 | 0.666 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.663 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.657 | |
| signal transduction involved in mitotic dna damage checkpoint | GO:1902402 | 3 | 0.654 | Human |
| positive regulation of neuron apoptotic process | GO:0043525 | 25 | 0.653 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.650 | Human |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.648 | |
| response to vitamin d | GO:0033280 | 3 | 0.647 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.641 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.641 | |
| response to ionizing radiation | GO:0010212 | 42 | 0.640 | |
| cellular response to x ray | GO:0071481 | 2 | 0.639 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.634 | |
| intrinsic apoptotic signaling pathway by p53 class mediator | GO:0072332 | 35 | 0.633 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.630 | |
| mitochondrial dna repair | GO:0043504 | 3 | 0.628 | |
| activation of cysteine type endopeptidase activity involved in apoptotic signaling pathway | GO:0097296 | 2 | 0.626 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.620 | |
| nitric oxide mediated signal transduction | GO:0007263 | 4 | 0.614 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.614 | |
| establishment or maintenance of cytoskeleton polarity | GO:0030952 | 2 | 0.612 | |
| apoptotic process involved in embryonic digit morphogenesis | GO:1902263 | 3 | 0.610 | |
| positive regulation of glial cell proliferation | GO:0060252 | 4 | 0.609 | |
| endothelial cell apoptotic process | GO:0072577 | 9 | 0.609 | |
| negative regulation of oxidative stress induced cell death | GO:1903202 | 9 | 0.604 | |
| signal transduction involved in mitotic cell cycle checkpoint | GO:0072413 | 3 | 0.603 | Human |
| regulation of somitogenesis | GO:0014807 | 6 | 0.600 | |
| dna damage response signal transduction by p53 class mediator resulting in cell cycle arrest | GO:0006977 | 3 | 0.597 | Human |
| pole plasm assembly | GO:0007315 | 2 | 0.596 | |
| urogenital system development | GO:0001655 | 261 | 0.595 | Mouse |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.589 | Mouse |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.586 | |
| positive regulation of mammary gland involution | GO:1903521 | 4 | 0.585 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.584 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.582 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.577 | Human Mouse |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.576 | |
| cellular response to metal ion | GO:0071248 | 31 | 0.573 | |
| placenta blood vessel development | GO:0060674 | 31 | 0.572 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.571 | |
| mapk cascade | GO:0000165 | 281 | 0.568 | |
| response to x ray | GO:0010165 | 11 | 0.568 | |
| regulation of response to oxidative stress | GO:1902882 | 19 | 0.565 | |
| digestive system development | GO:0055123 | 200 | 0.564 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.563 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.557 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.557 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.554 | |
| regulation of cyclin dependent protein serine threonine kinase activity | GO:0000079 | 16 | 0.553 | |
| positive regulation of striated muscle cell apoptotic process | GO:0010663 | 3 | 0.547 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.545 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.544 | |
| negative regulation of extrinsic apoptotic signaling pathway via death domain receptors | GO:1902042 | 11 | 0.542 | |
| cerebral cortex development | GO:0021987 | 86 | 0.541 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.535 | Human |
| regulation of transcription from rna polymerase ii promoter in response to oxidative stress | GO:0043619 | 2 | 0.534 | |
| regulation of fibroblast proliferation | GO:0048145 | 34 | 0.529 | Human |
| lymphocyte differentiation | GO:0030098 | 242 | 0.520 | |
| response to hyperoxia | GO:0055093 | 2 | 0.519 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.516 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.514 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.508 | |
| amine metabolic process | GO:0009308 | 45 | 0.507 | |
| regulation of mitochondrial membrane permeability involved in apoptotic process | GO:1902108 | 14 | 0.499 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.499 | |
| negative regulation of lipid kinase activity | GO:0090219 | 1 | 0.496 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.495 | Mouse |
| ectopic germ cell programmed cell death | GO:0035234 | 9 | 0.495 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.494 | Mouse |
| kidney development | GO:0001822 | 213 | 0.493 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.483 | |
| protein processing | GO:0016485 | 163 | 0.481 | |
| cell adhesion | GO:0007155 | 329 | 0.481 | |
| negative regulation of intrinsic apoptotic signaling pathway | GO:2001243 | 34 | 0.480 | |
| regulation of p38mapk cascade | GO:1900744 | 3 | 0.480 | |
| regulation of blood coagulation | GO:0030193 | 28 | 0.479 | |
| t cell activation | GO:0042110 | 289 | 0.475 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.473 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.473 | Human |
| negative regulation of lymphocyte apoptotic process | GO:0070229 | 24 | 0.471 | |
| positive regulation of p38mapk cascade | GO:1900745 | 1 | 0.470 | |
| pallium development | GO:0021543 | 120 | 0.469 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.469 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.466 | |
| positive regulation of cell cycle phase transition | GO:1901989 | 17 | 0.460 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.460 | |
| positive regulation of cell cycle g1 s phase transition | GO:1902808 | 9 | 0.460 | |
| skeletal system development | GO:0001501 | 356 | 0.459 | |
| wound healing | GO:0042060 | 157 | 0.457 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.453 | Human |
| response to nutrient levels | GO:0031667 | 109 | 0.451 | |
| response to inorganic substance | GO:0010035 | 96 | 0.447 | |
| response to amino acid | GO:0043200 | 37 | 0.442 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.442 | |
| negative regulation of endothelial cell migration | GO:0010596 | 4 | 0.442 | |
| positive regulation of apoptotic process involved in morphogenesis | GO:1902339 | 4 | 0.441 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.439 | |
| mammary gland epithelial cell proliferation | GO:0033598 | 24 | 0.433 | |
| labyrinthine layer development | GO:0060711 | 49 | 0.433 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.432 | |
| negative regulation of ubiquitin protein transferase activity | GO:0051444 | 3 | 0.428 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.428 | |
| regulation of oxidative stress induced intrinsic apoptotic signaling pathway | GO:1902175 | 9 | 0.427 | |
| cell cycle g1 s phase transition | GO:0044843 | 57 | 0.413 | Human Mouse |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.413 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.413 | |
| regulation of endothelial cell apoptotic process | GO:2000351 | 9 | 0.401 | |
| response to hypoxia | GO:0001666 | 58 | 0.400 | |
| apoptotic mitochondrial changes | GO:0008637 | 48 | 0.398 | |
| positive regulation of leukocyte differentiation | GO:1902107 | 86 | 0.396 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.396 | Mouse |
| regulation of peptidase activity | GO:0052547 | 96 | 0.395 | |
| modulation by virus of host morphology or physiology | GO:0019048 | 3 | 0.394 | |
| spermatid differentiation | GO:0048515 | 115 | 0.394 | |
| positive regulation of angiogenesis | GO:0045766 | 46 | 0.385 | |
| positive regulation of lymphocyte apoptotic process | GO:0070230 | 13 | 0.384 | |
| t cell selection | GO:0045058 | 34 | 0.384 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.384 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.381 | Human |
| positive regulation of protein oligomerization | GO:0032461 | 4 | 0.378 | |
| negative regulation of map kinase activity | GO:0043407 | 34 | 0.372 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.370 | |
| oocyte differentiation | GO:0009994 | 35 | 0.369 | |
| response to vitamin a | GO:0033189 | 1 | 0.367 | |
| embryonic placenta development | GO:0001892 | 98 | 0.366 | |
| mitochondrial membrane organization | GO:0007006 | 26 | 0.363 | |
| keratinocyte migration | GO:0051546 | 3 | 0.359 | |
| cell growth | GO:0016049 | 130 | 0.358 | Human |
| developmental maturation | GO:0021700 | 193 | 0.358 | |
| protein maturation | GO:0051604 | 176 | 0.357 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.356 | |
| epithelial cell differentiation involved in prostate gland development | GO:0060742 | 13 | 0.356 | |
| negative regulation of protein serine threonine kinase activity | GO:0071901 | 49 | 0.356 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.356 | |
| positive regulation of mitotic cell cycle phase transition | GO:1901992 | 17 | 0.354 | |
| renal system development | GO:0072001 | 225 | 0.351 | |
| regulation of oxidative stress induced neuron intrinsic apoptotic signaling pathway | GO:1903376 | 3 | 0.348 | |
| regulation of cell activation | GO:0050865 | 289 | 0.348 | |
| positive regulation of extrinsic apoptotic signaling pathway via death domain receptors | GO:1902043 | 13 | 0.346 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.346 | |
| protein ubiquitination | GO:0016567 | 171 | 0.343 | |
| regulation of transcription from rna polymerase ii promoter in response to hypoxia | GO:0061418 | 2 | 0.343 | |
| positive regulation of mitochondrial membrane permeability | GO:0035794 | 12 | 0.340 | |
| cellular response to decreased oxygen levels | GO:0036294 | 18 | 0.339 | |
| tissue remodeling | GO:0048771 | 102 | 0.339 | |
| negative regulation of syncytium formation by plasma membrane fusion | GO:0034242 | 5 | 0.336 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.335 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.333 | |
| t cell differentiation | GO:0030217 | 174 | 0.329 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.326 | |
| response to uv | GO:0009411 | 44 | 0.324 | |
| sprouting angiogenesis | GO:0002040 | 26 | 0.324 | |
| negative regulation of cellular response to oxidative stress | GO:1900408 | 10 | 0.324 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.323 | |
| glomerulus development | GO:0032835 | 40 | 0.323 | |
| regulation of blood vessel remodeling | GO:0060312 | 3 | 0.322 | |
| negative regulation of response to oxidative stress | GO:1902883 | 10 | 0.320 | |
| jnk cascade | GO:0007254 | 72 | 0.315 | |
| oocyte construction | GO:0007308 | 2 | 0.313 | |
| centrosome organization | GO:0051297 | 26 | 0.311 | |
| forebrain development | GO:0030900 | 302 | 0.307 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.306 | |
| hair follicle morphogenesis | GO:0031069 | 29 | 0.304 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 62 | 0.304 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.304 | |
| b cell activation | GO:0042113 | 161 | 0.303 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.301 | |
| positive regulation of protein complex assembly | GO:0031334 | 45 | 0.300 | Mouse |
| negative regulation of cell cycle arrest | GO:0071157 | 1 | 0.300 | |
| negative regulation of photoreceptor cell differentiation | GO:0046533 | 4 | 0.295 | |
| segmentation | GO:0035282 | 93 | 0.295 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.294 | Human |
| response to oxygen levels | GO:0070482 | 62 | 0.289 | |
| negative regulation of interferon gamma mediated signaling pathway | GO:0060336 | 1 | 0.288 | |
| zymogen activation | GO:0031638 | 41 | 0.287 | |
| protein catabolic process | GO:0030163 | 221 | 0.287 | |
| response to chromate | GO:0046687 | 1 | 0.285 | |
| lymphocyte homeostasis | GO:0002260 | 64 | 0.285 | |
| glial cell apoptotic process | GO:0034349 | 3 | 0.282 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.282 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.281 | |
| female genitalia morphogenesis | GO:0048807 | 3 | 0.280 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.279 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.279 | |
| odontogenesis | GO:0042476 | 78 | 0.278 | |
| actin filament organization | GO:0007015 | 113 | 0.278 | |
| regulation of b cell activation | GO:0050864 | 81 | 0.276 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.276 | Human |
| negative regulation of transcription involved in g1 s transition of mitotic cell cycle | GO:0071930 | 1 | 0.275 | |
| positive regulation of mitotic cell cycle | GO:0045931 | 41 | 0.274 | |
| regulation of cellular response to oxidative stress | GO:1900407 | 19 | 0.274 | |
| positive regulation of histone modification | GO:0031058 | 28 | 0.274 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.272 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.272 | Human |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.272 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.272 | |
| mitotic cell cycle arrest | GO:0071850 | 4 | 0.272 | |
| response to lithium ion | GO:0010226 | 10 | 0.271 | |
| positive regulation of cell cycle process | GO:0090068 | 61 | 0.270 | Human |
| response to organophosphorus | GO:0046683 | 22 | 0.269 | |
| plasma membrane long chain fatty acid transport | GO:0015911 | 1 | 0.262 | |
| positive regulation of extrinsic apoptotic signaling pathway | GO:2001238 | 34 | 0.261 | |
| extrinsic apoptotic signaling pathway via death domain receptors | GO:0008625 | 34 | 0.258 | |
| negative regulation of glial cell proliferation | GO:0060253 | 4 | 0.258 | |
| pharynx development | GO:0060465 | 1 | 0.257 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.256 | |
| cell chemotaxis | GO:0060326 | 81 | 0.253 | |
| negative regulation of lipid metabolic process | GO:0045833 | 30 | 0.250 | |
| regulation of protein processing | GO:0070613 | 96 | 0.250 | |
| dendrite development | GO:0016358 | 115 | 0.248 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.248 | |
| mitochondrion degradation | GO:0000422 | 3 | 0.247 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.244 | |
| regulation of epidermal cell division | GO:0010482 | 3 | 0.243 | |
| response to growth factor | GO:0070848 | 198 | 0.240 | |
| negative regulation of dendritic spine development | GO:0061000 | 3 | 0.240 | |
| mitotic sister chromatid cohesion | GO:0007064 | 1 | 0.240 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.238 | |
| regulation of wound healing | GO:0061041 | 40 | 0.237 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.235 | |
| microtubule depolymerization | GO:0007019 | 15 | 0.234 | |
| regulation of protein stability | GO:0031647 | 52 | 0.232 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.230 | |
| regulation of tissue remodeling | GO:0034103 | 38 | 0.229 | |
| neuronal action potential | GO:0019228 | 54 | 0.226 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.226 | Human |
| negative regulation of cellular protein catabolic process | GO:1903363 | 22 | 0.225 | |
| calcium ion transport | GO:0006816 | 159 | 0.225 | |
| regulation of mammary gland involution | GO:1903519 | 4 | 0.223 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 43 | 0.223 | |
| signal transduction by p53 class mediator | GO:0072331 | 51 | 0.223 | |
| positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator | GO:1902255 | 2 | 0.221 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.219 | |
| cellular response to prostaglandin stimulus | GO:0071379 | 2 | 0.218 | |
| positive regulation of muscle cell apoptotic process | GO:0010661 | 6 | 0.218 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.216 | |
| regulation of leukocyte apoptotic process | GO:2000106 | 56 | 0.216 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.215 | |
| macrophage differentiation | GO:0030225 | 20 | 0.215 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.210 | |
| stem cell maintenance | GO:0019827 | 130 | 0.210 | |
| face morphogenesis | GO:0060325 | 29 | 0.210 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.210 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.210 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.209 | |
| female gamete generation | GO:0007292 | 74 | 0.208 | |
| neuroblast fate determination | GO:0007400 | 1 | 0.207 | |
| dna metabolic process | GO:0006259 | 303 | 0.206 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.205 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.205 | |
| negative regulation of transcription from rna polymerase ii promoter in response to stress | GO:0097201 | 1 | 0.204 | |
| response to light stimulus | GO:0009416 | 135 | 0.204 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.204 | |
| notch signaling pathway | GO:0007219 | 71 | 0.204 | |
| regulation of fibrinolysis | GO:0051917 | 1 | 0.203 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.202 | Mouse |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.202 | |
| regulation of protein targeting | GO:1903533 | 61 | 0.202 | |
| b cell apoptotic process | GO:0001783 | 19 | 0.201 | |
| positive regulation of protein acetylation | GO:1901985 | 9 | 0.201 | |
| regulation of anoikis | GO:2000209 | 2 | 0.200 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.199 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.198 | |
| axonogenesis | GO:0007409 | 274 | 0.198 | |
| positive regulation of osteoclast differentiation | GO:0045672 | 15 | 0.196 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.194 | |
| blood vessel endothelial cell migration | GO:0043534 | 23 | 0.194 | |
| nuclear division | GO:0000280 | 158 | 0.194 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.194 | |
| organ growth | GO:0035265 | 117 | 0.193 | |
| cellular response to ionizing radiation | GO:0071479 | 11 | 0.193 | |
| regulation of endothelial cell chemotaxis | GO:2001026 | 1 | 0.192 | |
| positive regulation of myeloid leukocyte differentiation | GO:0002763 | 26 | 0.192 | |
| proteasomal protein catabolic process | GO:0010498 | 98 | 0.191 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.191 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.191 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.190 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.190 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.190 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.189 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.188 | Mouse |
| myeloid cell apoptotic process | GO:0033028 | 22 | 0.188 | |
| negative regulation of cell growth | GO:0030308 | 44 | 0.188 | Human |
| limb development | GO:0060173 | 166 | 0.185 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.185 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.183 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.182 | |
| fibroblast growth factor receptor signaling pathway | GO:0008543 | 46 | 0.181 | |
| appendage development | GO:0048736 | 166 | 0.180 | |
| regulation of membrane permeability | GO:0090559 | 18 | 0.180 | |
| regulation of t cell differentiation | GO:0045580 | 83 | 0.180 | |
| prostate gland development | GO:0030850 | 48 | 0.180 | Mouse |
| circulatory system process | GO:0003013 | 197 | 0.179 | |
| platelet derived growth factor receptor alpha signaling pathway | GO:0035790 | 3 | 0.179 | |
| response to peptide | GO:1901652 | 136 | 0.177 | |
| growth involved in heart morphogenesis | GO:0003241 | 4 | 0.176 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.176 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 55 | 0.175 | |
| actin filament bundle assembly | GO:0051017 | 40 | 0.175 | |
| myeloid leukocyte activation | GO:0002274 | 83 | 0.174 | |
| positive t cell selection | GO:0043368 | 23 | 0.174 | |
| liposaccharide metabolic process | GO:1903509 | 27 | 0.174 | |
| regulation of cell cycle g1 s phase transition | GO:1902806 | 35 | 0.173 | Human |
| regulation of vasculature development | GO:1901342 | 88 | 0.172 | |
| response to ischemia | GO:0002931 | 14 | 0.172 | |
| cytokine production | GO:0001816 | 319 | 0.171 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.170 | |
| positive regulation of mitotic sister chromatid separation | GO:1901970 | 2 | 0.167 | |
| cell death in response to oxidative stress | GO:0036473 | 24 | 0.166 | |
| cellular response to amino acid stimulus | GO:0071230 | 29 | 0.166 | |
| negative regulation of endopeptidase activity | GO:0010951 | 44 | 0.165 | |
| p38mapk cascade | GO:0038066 | 4 | 0.165 | |
| regulation of stress activated mapk cascade | GO:0032872 | 69 | 0.165 | |
| liver development | GO:0001889 | 66 | 0.164 | |
| regulation of hemostasis | GO:1900046 | 28 | 0.164 | |
| negative regulation of keratinocyte differentiation | GO:0045617 | 4 | 0.163 | |
| glycolipid metabolic process | GO:0006664 | 25 | 0.163 | |
| modification by symbiont of host morphology or physiology | GO:0044003 | 4 | 0.162 | |
| glomerular capillary formation | GO:0072104 | 6 | 0.162 | |
| regulation of cellular response to hypoxia | GO:1900037 | 2 | 0.161 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.161 | |
| cgmp mediated signaling | GO:0019934 | 3 | 0.161 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.160 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.159 | |
| endothelial cell proliferation | GO:0001935 | 27 | 0.159 | |
| positive regulation of mitochondrion organization | GO:0010822 | 17 | 0.159 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.159 | |
| response to tumor necrosis factor | GO:0034612 | 26 | 0.157 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.156 | |
| epidermis development | GO:0008544 | 187 | 0.156 | |
| cell migration involved in endocardial cushion formation | GO:0003273 | 3 | 0.155 | |
| membrane organization | GO:0061024 | 245 | 0.155 | |
| stress response to metal ion | GO:0097501 | 3 | 0.155 | |
| regulation of b cell differentiation | GO:0045577 | 23 | 0.155 | |
| telencephalon development | GO:0021537 | 186 | 0.154 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.153 | |
| hypoxia inducible factor 1alpha signaling pathway | GO:0097411 | 2 | 0.152 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.151 | |
| hippocampus development | GO:0021766 | 52 | 0.151 | |
| response to hydrogen peroxide | GO:0042542 | 32 | 0.151 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.151 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.151 | |
| traversing start control point of mitotic cell cycle | GO:0007089 | 2 | 0.150 | |
| negative regulation of peptidase activity | GO:0010466 | 46 | 0.150 | |
| regulation of myeloid leukocyte differentiation | GO:0002761 | 58 | 0.149 | |
| dephosphorylation | GO:0016311 | 129 | 0.146 | |
| maternal determination of anterior posterior axis embryo | GO:0008358 | 2 | 0.146 | |
| negative regulation of lymphocyte differentiation | GO:0045620 | 32 | 0.145 | |
| dna damage response signal transduction by p53 class mediator resulting in transcription of p21 class mediator | GO:0006978 | 2 | 0.145 | |
| response to corticosterone | GO:0051412 | 1 | 0.145 | |
| placenta development | GO:0001890 | 140 | 0.144 | |
| negative regulation of anoikis | GO:2000811 | 2 | 0.144 | |
| renal system vasculature morphogenesis | GO:0061438 | 7 | 0.144 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.143 | |
| response to corticosteroid | GO:0031960 | 20 | 0.142 | |
| regulation of lipid kinase activity | GO:0043550 | 14 | 0.142 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.142 | |
| positive regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway | GO:0035793 | 1 | 0.142 | |
| response to drug | GO:0042493 | 75 | 0.141 | |
| receptor biosynthetic process | GO:0032800 | 3 | 0.141 | |
| mitochondrial transport | GO:0006839 | 36 | 0.141 | |
| neuroblast differentiation | GO:0014016 | 2 | 0.140 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.140 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.140 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 45 | 0.140 | Human |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.139 | |
| skin development | GO:0043588 | 220 | 0.139 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.138 | |
| dna replication | GO:0006260 | 52 | 0.138 | |
| multicellular organismal metabolic process | GO:0044236 | 28 | 0.138 | |
| cellular response to hypoxia | GO:0071456 | 17 | 0.138 | |
| epidermis morphogenesis | GO:0048730 | 33 | 0.137 | |
| positive regulation of keratinocyte differentiation | GO:0045618 | 3 | 0.136 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.135 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.134 | |
| neutrophil apoptotic process | GO:0001781 | 3 | 0.134 | |
| cell cycle checkpoint | GO:0000075 | 47 | 0.134 | Human |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.133 | |
| dendritic spine maintenance | GO:0097062 | 4 | 0.133 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.132 | |
| b cell lineage commitment | GO:0002326 | 4 | 0.132 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.132 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.131 | |
| regulation of ion transport | GO:0043269 | 215 | 0.131 | |
| regulation of developmental pigmentation | GO:0048070 | 14 | 0.131 | |
| tissue migration | GO:0090130 | 68 | 0.130 | |
| leukocyte homeostasis | GO:0001776 | 79 | 0.129 | |
| regulation of ubiquitin protein transferase activity | GO:0051438 | 7 | 0.128 | |
| inflammatory response | GO:0006954 | 244 | 0.128 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.127 | |
| signal transduction involved in mitotic g1 dna damage checkpoint | GO:0072431 | 3 | 0.127 | Human |
| oocyte development | GO:0048599 | 33 | 0.127 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.127 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.126 | |
| smooth muscle tissue development | GO:0048745 | 22 | 0.125 | |
| microtubule organizing center organization | GO:0031023 | 28 | 0.125 | |
| regulation of coagulation | GO:0050818 | 31 | 0.124 | |
| organelle fission | GO:0048285 | 170 | 0.124 | |
| b cell differentiation | GO:0030183 | 78 | 0.123 | |
| rrna transcription | GO:0009303 | 9 | 0.123 | |
| regulation of notch signaling pathway | GO:0008593 | 35 | 0.123 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.122 | Mouse |
| activation of cysteine type endopeptidase activity | GO:0097202 | 27 | 0.122 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.121 | |
| regulation of g1 s transition of mitotic cell cycle | GO:2000045 | 35 | 0.121 | Human |
| cloacal septation | GO:0060197 | 2 | 0.120 | |
| positive regulation of coagulation | GO:0050820 | 13 | 0.120 | |
| response to starvation | GO:0042594 | 65 | 0.120 | |
| response to increased oxygen levels | GO:0036296 | 2 | 0.120 | |
| protein localization to organelle | GO:0033365 | 185 | 0.120 | |
| regulation of epidermal cell differentiation | GO:0045604 | 21 | 0.120 | |
| long chain fatty acid transport | GO:0015909 | 15 | 0.119 | |
| single organism nuclear import | GO:1902593 | 95 | 0.119 | |
| photoreceptor cell differentiation | GO:0046530 | 52 | 0.119 | |
